Calamos Advisors LLC Acquires 3,316 Shares of Agilent Technologies, Inc. $A

Calamos Advisors LLC grew its holdings in Agilent Technologies, Inc. (NYSE:A) by 2.1% during the 3rd quarter, Holdings Channel reports. The firm owned 163,901 shares of the medical research company’s stock after buying an additional 3,316 shares during the period. Calamos Advisors LLC’s holdings in Agilent Technologies were worth $28,242,000 at the end of the most recent reporting period.

Several other institutional investors have also recently modified their holdings of A. Bank of New York Mellon Corp grew its holdings in Agilent Technologies by 87.4% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock valued at $695,227,000 after buying an additional 2,440,360 shares during the last quarter. Legal & General Group Plc acquired a new position in shares of Agilent Technologies in the second quarter worth $260,101,000. Bank of America Corp DE acquired a new position in shares of Agilent Technologies in the second quarter worth $213,269,000. Man Group plc purchased a new stake in shares of Agilent Technologies in the second quarter valued at $179,257,000. Finally, Primecap Management Co. CA purchased a new stake in shares of Agilent Technologies in the second quarter valued at $176,318,000.

Agilent Technologies Trading Up 1.7%

Agilent Technologies stock traded up $3.01 during trading on Friday, reaching $174.79. The company had a trading volume of 2,048,423 shares, compared to its average volume of 2,094,801. The stock’s 50 day moving average price is $165.94 and its two-hundred day moving average price is $137.20. The firm has a market capitalization of $49.28 billion, a price-to-earnings ratio of 34.41, a PEG ratio of 2.52 and a beta of 1.24. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $182.99.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The business had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. During the same period in the previous year, the company posted $1.37 EPS. The company’s revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. As a group, equities analysts expect that Agilent Technologies, Inc. will post 6.20 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, October 28th. Stockholders of record on Tuesday, October 6th were given a $0.2550 dividend. The ex-dividend date of this dividend was Tuesday, October 6th. This represents a $1.02 annualized dividend and a dividend yield of 0.6%. Agilent Technologies’s dividend payout ratio is presently 20.08%.

Insider Activity at Agilent Technologies

In other news, Director Mikael Dolsten sold 634 shares of the firm’s stock in a transaction on Friday, September 4th. The shares were sold at an average price of $151.38, for a total value of $95,974.92. Following the transaction, the director owned 4,924 shares of the company’s stock, valued at approximately $745,395.12. This trade represents a 11.41% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Wall Street Analyst Weigh In

A number of research firms recently commented on A. Piper Sandler increased their price objective on Agilent Technologies from $150.00 to $160.00 and gave the company a “neutral” rating in a research note on Friday, August 28th. HSBC upped their target price on shares of Agilent Technologies from $165.00 to $175.00 and gave the company a “buy” rating in a report on Tuesday, September 1st. Sanford C. Bernstein boosted their price objective on shares of Agilent Technologies from $155.00 to $180.00 and gave the company an “outperform” rating in a research report on Thursday, August 27th. Deutsche Bank Aktiengesellschaft started coverage on shares of Agilent Technologies in a research note on Monday, October 26th. They set a “buy” rating and a $190.00 price objective on the stock. Finally, JPMorgan Chase & Co. raised their target price on shares of Agilent Technologies from $190.00 to $195.00 in a research report on Wednesday, October 14th. Eighteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $181.45.

Agilent Technologies Profile

Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research.

The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.

Agilent became an independent company in 1999 through a spin-off from Hewlett-Packard.